@article{oai:morinomiya.repo.nii.ac.jp:00000202,
 author = {藤江, 建朗 and Fujie, Tatsuro},
 journal = {森ノ宮医療大学紀要, Bulletin of Morinomiya University of Medical Sciences},
 month = {Apr},
 note = {睡眠時無呼吸症候群の患者数は年々増加傾向にある．また，肥満男性のみが罹患するという認識から，年代，性別や肥満度を問わず罹患する日常で遭遇する頻度の高い疾患として知られるようになった．睡眠は人生の約三割を占めているが，睡眠という行為自体が意識下では無いため症状を自覚するまでに時間を要する．そのため，多くの研究で診断の遅れや多数の未治療者が存在すると報告されている．平成30年の厚生労働省の社会医療診療行為別統計では，睡眠時無呼吸症候群の代表的な治療法であるCPAP療法の患者数は約44万人であったと報告されている．しかし，我が国の無呼吸低呼吸指数が15以上の推定患者数は900万人も存在するという報告もあり，診療体制の強化以外に，睡眠検査の従事者数増加，治療体制の強化，患者支援などを多職種で連携しチーム医療で行うことが必要である．, The incidence of sleep apnea syndrome is on the rise each year. The earlier perception that it affects only obese men has been replaced with the recognition that it is a widely prevalent disorder affecting people of all ages, genders, and body mass indices. Sleep comprises about 30% of our lifespan; however, most people are unaware of the symptoms of the disorder because sleep itself is not a self-conscious act. Therefore, several studies have reported delays in the diagnosis of sleep apnea, leading to a large population of untreated individuals. According to the Statistics of Medical Care Activities in Public Health Insurance published in 2018 by the Ministry of Health, Labour and Welfare, Japan, approximately 440,000 people received continuous positive airway pressure (CPAP) therapy, a typical treatment for sleep apnea syndrome. Another report estimated that as many as 9 million people have an apnea-hypopnea index of > 15 in Japan. Thus, in addition to strengthening the medical care system, it is necessary to increase the number of support staff for sleep testing, strengthen the treatment facilities, and provide patient care through multidisciplinary collaboration and team efforts.},
 pages = {81--88},
 title = {睡眠時無呼吸症候群},
 volume = {16},
 year = {2022},
 yomi = {フジエ, タツロウ}
}